Minerva Neurosciences | NERV - Активы





Активы Изменить Дата
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Adma Biologics USD 684.21M 19.03M 2026-06
ALKERMES USD 4.39B 135.05M 2026-06
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
AstraZeneca USD 115.83B 1.82B 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Cipla INR 424.96B 23.32B 2026-03
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 145.86M 10.71M 2026-03
CSL USD 37.9B 1.5B 2025-12
Eli Lilly USD 142.28B 25.71B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Grifols EUR 23.15B 142.7M 2025-12
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
J&J USD 201.06B 167M 2026-06
Merck USD 129.8B 1.12B 2026-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novartis USD 122.03B 3.5B 2026-06
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Takeda JPY 15.66T 210.16B 2026-06
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12